Goldman's 'Buyback' Basket: CMCSA, GM, MPC, Etc
Tesla, General Motors, AT&T, and More Stocks to Watch
Earnings Preview: LH to Report Financial Results Pre-market on October 24
$Labcorp Holdings(LH.US)$ is scheduled to release its financial results pre-market on October 24 ET. Earnings PreviewAnalysts estimate $Labcorp Holdings(LH.US)$ to post revenue of USD3.26B for 2024Q3,
Laboratory Corp. Is Maintained at Equal-Weight by Barclays
Express News | Nowdiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
NOWDiagnostics and Labcorp Collaborate to Expand Access to the Only FDA-Marketing Authorized Over-the-Counter Syphilis Test in the U.S.
Barclays Maintains Labcorp Holdings(LH.US) With Hold Rating, Cuts Target Price to $234
Morgan Stanley Maintains Labcorp Holdings(LH.US) With Buy Rating, Maintains Target Price $260
Labcorp's Q3 Earnings Looms: Here's What to Expect From the Stock
Is The Market Rewarding Labcorp Holdings Inc. (NYSE:LH) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?
Labcorp Holdings To Go Ex-Dividend On November 26th, 2024 With 0.72 USD Dividend Per Share
October 10th (Eastern Time) - $Labcorp Holdings(LH.US)$ is trading ex-dividend on November 26th, 2024.Shareholders of record on November 26th, 2024 will receive 0.72 USD dividend per share on
Express News | Labcorp: Plans to Make Test Available to Providers by End of 2024 and Directly to Patients Through Labcorp Ondemand in 2025
Express News | Labcorp Expands Sexually Transmitted Infection (Sti) Test Offerings With Rapid Syphilis Test
Labcorp Expands Sexually Transmitted Infection (STI) Test Offerings With Rapid Syphilis Test
Labcorp Holdings Keeps Dividend at $0.72 per Share; Payable Dec. 13 to Shareholders of Record on Nov. 26
Press Release: Labcorp Declares Quarterly Dividend
What to Expect From Labcorp Holdings' Q3 2024 Earnings Report
WHO Approves First Mpox Diagnostic Test for Emergency Use
Express News | Labcorp : BofA Global Research Raises Price Objective to $262 From $260
Piper Sandler Initiates Labcorp Holdings(LH.US) With Hold Rating, Announces Target Price $235